{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:00:38Z","timestamp":1794348038740,"version":"4.9.0"},"reference-count":82,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107660\/Z\/15Z"],"award-info":[{"award-number":["107660\/Z\/15Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204337\/Z\/16\/Z"],"award-info":[{"award-number":["204337\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/M027546\/1"],"award-info":[{"award-number":["EP\/M027546\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J014400\/1"],"award-info":[{"award-number":["BB\/J014400\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["107660\/Z\/15Z"],"award-info":[{"award-number":["107660\/Z\/15Z"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Expression of \u03b2-lactamase is the single most prevalent determinant of antibiotic resistance, rendering bacteria resistant to \u03b2-lactam antibiotics. In this article, we describe the development of an antibiotic prodrug that combines ciprofloxacin with a \u03b2-lactamase-cleavable motif. The prodrug is only bactericidal after activation by \u03b2-lactamase. Bactericidal activity comparable to ciprofloxacin is demonstrated against clinically relevant E. coli isolates expressing diverse \u03b2-lactamases; bactericidal activity was not observed in strains without \u03b2-lactamase. These findings demonstrate that it is possible to exploit antibiotic resistance to selectively target \u03b2-lactamase-producing bacteria using our prodrug approach, without adversely affecting bacteria that do not produce \u03b2-lactamase. This paves the way for selective targeting of drug-resistant pathogens without disrupting or selecting for resistance within the microbiota, reducing the rate of secondary infections and subsequent antibiotic use.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.8b01923","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T17:05:06Z","timestamp":1555952706000},"page":"4411-4425","source":"Crossref","is-referenced-by-count":73,"title":["Exploitation of\nAntibiotic Resistance as a Novel Drug\nTarget: Development of a \u03b2-Lactamase-Activated Antibacterial\nProdrug"],"prefix":"10.1021","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-9329","authenticated-orcid":true,"given":"Lindsay E.","family":"Evans","sequence":"first","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]},{"name":"Imperial College London , , ,","place":["London, United Kingdom, W12 0BZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Krishna","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Ma","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, W12 0BZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Webb","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic C.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Tooke","sequence":"additional","affiliation":[{"name":"University of Bristol , , Biomedical Sciences Building, University Walk , ,","place":["Bristol, United Kingdom, BS8 1TD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-0571","authenticated-orcid":true,"given":"James","family":"Spencer","sequence":"additional","affiliation":[{"name":"University of Bristol , , Biomedical Sciences Building, University Walk , ,","place":["Bristol, United Kingdom, BS8 1TD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-3099","authenticated-orcid":true,"given":"Alan","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, W12 0BZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Imperial College London , , ,","place":["London, United Kingdom, SW7 2AZ"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"2026090218233043200_cit1","volume-title":"Antimicrobial\nResistance: Tackling a Crisis for the Health and Wealth of Nations","author":"O\u2019Neill","year":"2014"},{"key":"2026090218233043200_cit2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","article-title":"Update on the Antibiotic\nResistance Crisis","volume":"18","author":"Rossolini","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"2026090218233043200_cit3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","article-title":"Beta-Lactam\nAntibiotics: From Antibiosis\nto Resistance and Bacteriology","volume":"118","author":"Kong","year":"2010","journal-title":"APMIS."},{"issue":"1","key":"2026090218233043200_cit4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MRM.0b013e3283587727","article-title":"\u03b2-Lactams","volume":"24","author":"Fernandes","year":"2013","journal-title":"Rev. Med. Microbiol."},{"issue":"1","key":"2026090218233043200_cit5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/nyas.12023","article-title":"Proliferation\nand Significance of Clinically Relevant \u03b2-Lactamases","volume":"1277","author":"Bush","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2026090218233043200_cit6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M Enzymes:\nOrigin and Diffusion","volume":"3","author":"Canto\u0301n","year":"2012","journal-title":"Front. Microbiol."},{"issue":"1","key":"2026090218233043200_cit7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","article-title":"Antibiotic\nResistance and Extended Spectrum Beta-Lactamases: Types, Epidemiology\nand Treatment","volume":"22","author":"Shaikh","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"issue":"5","key":"2026090218233043200_cit8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary Tract Infections:\nEpidemiology, Mechanisms of Infection and Treatment Options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"2026090218233043200_cit9","doi-asserted-by":"publisher","first-page":"2333721416638980","DOI":"10.1177\/2333721416638980","article-title":"Risk Factors for\nUrosepsis in Older Adults: A Systematic Review","volume":"2","author":"Peach","year":"2016","journal-title":"Gerontol. Geriatr. Med."},{"issue":"1","key":"2026090218233043200_cit10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QCO.0000000000000228","article-title":"Global Epidemiology of Urinary Tract\nInfections","volume":"29","author":"Tandogdu","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"2026090218233043200_cit11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciy035","article-title":"Opportunities to Improve Fluoroquinolone\nPrescribing in the United States for Adult Ambulatory Care Visits","volume":"67","author":"Kabbani","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"2026090218233043200_cit12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid0901.020277","article-title":"Maintaining\nFluoroquinolone Class Efficacy: Review of Influencing Factors","volume":"9","author":"Scheld","year":"2003","journal-title":"Emerging Infect. Dis."},{"issue":"6","key":"2026090218233043200_cit13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-Induced\nChanges in the\nIntestinal Microbiota and Disease","volume":"22","author":"Becattini","year":"2016","journal-title":"Trends Mol.\nMed."},{"issue":"4","key":"2026090218233043200_cit14","doi-asserted-by":"publisher","first-page":"344.e1","DOI":"10.1016\/j.cmi.2014.11.016","article-title":"Collateral Damage from Oral Ciprofloxacin\nversus Nitrofurantoin in Outpatients with Urinary Tract Infections:\nA Culture-Free Analysis of Gut Microbiota","volume":"21","author":"Stewardson","year":"2015","journal-title":"Clin.\nMicrobiol. Infect."},{"issue":"Suppl. 1","key":"2026090218233043200_cit15","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete Recovery\nand Individualized Responses of\nthe Human Distal Gut Microbiota to Repeated Antibiotic Perturbation","volume":"108","author":"Dethlefsen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"2026090218233043200_cit16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect\nof Antimicrobial Agents on\nthe Ecological Balance of Human Microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"2026090218233043200_cit17","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-Term\nImpacts\nof Antibiotic Exposure on the Human Intestinal Microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"issue":"5","key":"2026090218233043200_cit18","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-Analysis of\nAntibiotics and the Risk of Community-Associated Clostridium Difficile\nInfection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"23","key":"2026090218233043200_cit19","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1002\/anie.201506818","article-title":"Targeting Antibiotic Resistance","volume":"55","author":"Chellat","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"issue":"5","key":"2026090218233043200_cit20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms\nfor Antibiotic Discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090218233043200_cit21","unstructured":"FDA.\nHighlights of prescribing information (ciprofloxacin hydrochloride). www.fda.gov\/medwatch (accessed\nOct 25, 2018)."},{"key":"2026090218233043200_cit22","unstructured":"Press\nAnnouncements. FDA updates warnings for fluoroquinolone antibiotics. https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm513183.htm (accessed Oct 24, 2018)."},{"issue":"7697","key":"2026090218233043200_cit23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/d41586-018-03267-5","article-title":"When Antibiotics\nTurn Toxic","volume":"555","author":"Marchant","year":"2018","journal-title":"Nature"},{"issue":"4","key":"2026090218233043200_cit24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of Control Interventions on Clostridium Difficile\nInfection in England: An Observational Study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"2026090218233043200_cit25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of\nOutpatient Antibiotics for Urinary Tract Infections on Antimicrobial\nResistance among Commensal Enterobacteriaceae: A Multinational Prospective\nCohort Study","volume":"24","author":"Stewardson","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"issue":"15","key":"2026090218233043200_cit26","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global Increase\nand Geographic Convergence in Antibiotic Consumption between 2000\nand 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090218233043200_cit27","volume-title":"Rapid Diagnostics:\nStopping Unnecessary Use of Antibiotics","author":"O\u2019Neill","year":"2015"},{"key":"2026090218233043200_cit28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jgar.2018.05.023","article-title":"Intestinal Microbiota as a Reservoir of Extended-Spectrum\n\u03b2-Lactamase-Producing Escherichia Coli: An Exploratory Study\nin Healthy University Students","volume":"14","author":"Mota","year":"2018","journal-title":"J. Glob. Antimicrob.\nResist."},{"issue":"3","key":"2026090218233043200_cit29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10096-018-3186-x","article-title":"Ceftriaxone Promotes the Emergence of AmpC-Overproducing\nEnterobacteriaceae in Gut Microbiota from Hospitalized Patients","volume":"37","author":"de Lastours","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"2026090218233043200_cit30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1099\/jmm.0.000399","article-title":"Detection\nof Escherichia Coli ST131 Clonal Complex\n(ST705) and Klebsiella Pneumoniae ST15 among Faecal Carriage of Extended-Spectrum\n\u03b2-Lactamase- and Carbapenemase-Producing Enterobacteriaceae","volume":"66","author":"Ri\u0301os","year":"2017","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"2026090218233043200_cit31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0960-894X(01)81083-0","article-title":"A Novel Targeted\nDelivery System Utilizing a Cephalosporin-Oncolytic Prodrug Activated\nby an Antibody \u03b2-Lactamase Conjugate for the Treatment of Cancer","volume":"1","author":"Shepherd","year":"1991","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"2026090218233043200_cit32","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1021\/jo00034a027","article-title":"Synthesis\nof Acylhydrazido-Substituted\nCephems. Design of Cephalosporin-Vinca Alkaloid Prodrugs: Substrates\nfor an Antibody Targeted Enzyme","volume":"57","author":"Jungheim","year":"1992","journal-title":"J. Org. Chem."},{"issue":"4","key":"2026090218233043200_cit33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/1074-5521(95)90272-4","article-title":"Synthesis and \u03b2-Lactamase-Mediated Activation\nof a Cephalosporin-Taxol Prodrug","volume":"2","author":"Rodrigues","year":"1995","journal-title":"Chem. Biol."},{"issue":"4","key":"2026090218233043200_cit34","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.bmcl.2008.12.057","article-title":"Design and Synthesis of a \u03b2-Lactamase\nActivated 5-Fluorouracil Prodrug","volume":"19","author":"Phelan","year":"2009","journal-title":"Bioorg. Med.\nChem. Lett."},{"issue":"2","key":"2026090218233043200_cit35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0960-894X(01)80902-1","article-title":"Synthesis and Release of Doxorubicin from a Cephalosporin\nBased Prodrug by a \u03b2-Lactamase-Immunoconjugate","volume":"3","author":"Hudyma","year":"1993","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"2026090218233043200_cit36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7164\/antibiotics.44.200","article-title":"Synthesis\nand Antibacterial Activity of New C-10 Quinolonyl-Cephem Esters","volume":"44","author":"Demuth","year":"1991","journal-title":"J. Antibiot."},{"issue":"10","key":"2026090218233043200_cit37","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1517\/13543784.6.10.1479","article-title":"Dual \u03b2-Lactam-Fluoroquinolone\nCompounds: A Novel Approach to Antibacterial Treatment","volume":"6","author":"Bryskier","year":"1997","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2","key":"2026090218233043200_cit38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/AAC.10.2.245","article-title":"A New Cephalosporin with a Dual Mode\nof Action","volume":"10","author":"O\u2019Callaghan","year":"1976","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"2026090218233043200_cit39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1128\/AAC.33.7.1067","article-title":"Mode of Action of\nthe Dual-Action Cephalosporin Ro 23-9424","volume":"33","author":"Georgopapadakou","year":"1989","journal-title":"Antimicrob.\nAgents Chemother."},{"issue":"3","key":"2026090218233043200_cit40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/jb.110.3.988-991.1972","article-title":"Correlation\nbetween Hydrolysis of the \u03b2-Lactam Bond of the Cephalosporin\nNucleus and Expulsion of the 3-Substituent","volume":"110","author":"O\u2019Callaghan","year":"1972","journal-title":"J. Bacteriol."},{"issue":"31","key":"2026090218233043200_cit41","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1016\/S0040-4020(00)00419-1","article-title":"\u03b2-Lactamase-Dependent\nProdrugs\u2500Recent Developments","volume":"56","author":"Smyth","year":"2000","journal-title":"Tetrahedron"},{"issue":"1","key":"2026090218233043200_cit42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1021\/jm00163a013","article-title":"Cephalosporin 3\u2032-Quinolone\nEsters with a Dual Mode of Action","volume":"33","author":"Albrecht","year":"1990","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026090218233043200_cit43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1099\/jmm.0.000475","article-title":"Mechanisms\nof Quinolone Action and Resistance: Where Do We Stand?","volume":"66","author":"Correia","year":"2017","journal-title":"J. Med. Microbiol."},{"issue":"Suppl. C","key":"2026090218233043200_cit44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/10.suppl_C.1","article-title":"Ceftizoxime\nand Other Third-Generation Cephalosporins: Structure-Activity Relationships","volume":"10","author":"Dunn","year":"1982","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"2026090218233043200_cit45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijantimicag.2011.01.017","article-title":"Ceftaroline:\nA Comprehensive Update","volume":"37","author":"Kaushik","year":"2011","journal-title":"Int. J. Antimicrob.\nAgents"},{"issue":"17","key":"2026090218233043200_cit46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0196-4399(97)82485-3","article-title":"Fourth-Generation\nCephalosporins","volume":"19","author":"Fung-Tomc","year":"1997","journal-title":"Clin. Microbiol. Newsl."},{"issue":"12","key":"2026090218233043200_cit47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0738-1751(92)90022-3","article-title":"Historical Overview of the Cephalosporin Spectrum:\nFour Generations of Structural Evolution","volume":"8","author":"Sader","year":"1992","journal-title":"Antimicrob.\nNewsl."},{"issue":"4","key":"2026090218233043200_cit48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0924-8579(95)00015-Z","article-title":"Oral Cephalosporins:\nCurrent Perspectives","volume":"5","author":"Garci\u0301a-Rodri\u0301guez","year":"1995","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl.\n2","key":"2026090218233043200_cit49","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1093\/clinids\/4.Supplement_2.S281","article-title":"Cephalosporins\nand Related Antibiotics: An Overview","volume":"4","author":"Turck","year":"1982","journal-title":"Clin.\nInfect. Dis."},{"issue":"8","key":"2026090218233043200_cit50","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/AAC.41.8.1649","article-title":"Structure-Activity\nRelationship of\nCarbacephalosporins and Cephalosporins: Antibacterial Activity and\nInteraction with the Intestinal Proton-Dependent Dipeptide Transport\nCarrier of Caco-2 Cells","volume":"41","author":"Snyder","year":"1997","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"2","key":"2026090218233043200_cit51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/07388550600718630","article-title":"Enzymatic\nModifications of Cephalosporins by Cephalosporin Acylase and Other\nEnzymes","volume":"26","author":"Sonawane","year":"2006","journal-title":"Crit. Rev. Biotechnol."},{"issue":"20","key":"2026090218233043200_cit52","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1021\/jm8007739","article-title":"Thiophene\nBioisosteres of Spirocyclic \u03c3 Receptor\nLigands. 1. N-Substituted Spiro[piperidine-4,4\u2019-thieno[3,2-c ]pyrans]","volume":"51","author":"Oberdorf","year":"2008","journal-title":"J. Med. Chem."},{"key":"2026090218233043200_cit53","doi-asserted-by":"crossref","DOI":"10.1002\/9783527654307","volume-title":"Bioisosteres in Medicinal\nChemistry","author":"Brown","year":"2012"},{"issue":"10","key":"2026090218233043200_cit54","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1023\/A:1012272403776","article-title":"The Development\nof \u03b2-Lactam Antibiotics in Response to the Evolution of \u03b2-Lactamases","volume":"18","author":"Essack","year":"2001","journal-title":"Pharm. Res."},{"issue":"10","key":"2026090218233043200_cit55","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1039\/P29880001815","article-title":"Hydrolysis\nof 7-Substituted Cephalosporins Catalysed by \u03b2-Lactamases I\nand II from Bacillus Cereus and by Hydroxide Ion","volume":"0","author":"Buckwell","year":"1988","journal-title":"J. Chem. Soc., Perkin Trans. 2"},{"issue":"14","key":"2026090218233043200_cit56","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1021\/acs.orglett.5b01634","article-title":"Pd(II)-Catalyzed\nDirect Sulfonylation of Unactivated\nC(Sp3)-H Bonds with Sodium Sulfinates","volume":"17","author":"Rao","year":"2015","journal-title":"Org. Lett."},{"issue":"6","key":"2026090218233043200_cit57","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/JCM.37.6.1758-1763.1999","article-title":"Survey\nof Extended-Spectrum\nBeta-Lactamases in Clinical Isolates of Escherichia coli and Klebsiella\npneumoniae: Prevalence of TEM-52 in Korea","volume":"37","author":"Pai","year":"1999","journal-title":"J.\nClin. Microbiol."},{"issue":"1","key":"2026090218233043200_cit58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.30.1.6","article-title":"Methodology for the Study of Beta-Lactamases","volume":"30","author":"Bush","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"2026090218233043200_cit59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1146\/annurev.mi.41.100187.003041","article-title":"Chromosomal\nCephalosporinases Responsible for Multiple Resistance to Newer \u03b2-Lactam\nAntibiotics","volume":"41","author":"Sanders","year":"1987","journal-title":"Annu. Rev. Microbiol."},{"issue":"16","key":"2026090218233043200_cit60","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1002\/anie.201410701","article-title":"Target-Based\nWhole-Cell Screening by 1 H-NMR Spectroscopy","volume":"54","author":"Ma","year":"2015","journal-title":"Angew. Chem., Int. Ed."},{"issue":"8","key":"2026090218233043200_cit61","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/anie.201308636","article-title":"Real-Time\nMonitoring of New Delhi\nMetallo-\u03b2-Lactamase Activity in Living Bacterial Cells by 1 H-NMR Spectroscopy","volume":"53","author":"Ma","year":"2014","journal-title":"Angew. Chem., Int.\nEd."},{"issue":"26","key":"2026090218233043200_cit62","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1073\/pnas.252529799","article-title":"Extensive Mosaic\nStructure Revealed by the Complete Genome Sequence of Uropathogenic\nEscherichia coli","volume":"99","author":"Welch","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.\nS. A."},{"issue":"5","key":"2026090218233043200_cit63","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/iai.58.5.1281-1289.1990","article-title":"Pyelonephritogenic\nEscherichia coli and Killing of Cultured Human Renal Proximal Tubular\nEpithelial Cells: Role of Hemolysin in Some Strains","volume":"58","author":"Mobley","year":"1990","journal-title":"Infect. Immun."},{"key":"2026090218233043200_cit64","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/IDR.S156995","article-title":"Understanding Antibiotic Resistance\nvia Outer Membrane Permeability","volume":"11","author":"Ghai","year":"2018","journal-title":"Infect. Drug\nResist."},{"issue":"1","key":"2026090218233043200_cit65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1021\/tx3003824","article-title":"Reactive\nMetabolites in the Biotransformation of Molecules Containing a Furan\nRing","volume":"26","author":"Peterson","year":"2013","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"2026090218233043200_cit66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6769-1-4","article-title":"Synthesis\nand Preliminary Cytotoxicity Study of a Cephalosporin-CC-1065 Analogue\nProdrug","volume":"1","author":"Wang","year":"2001","journal-title":"BMC Chem. Biol."},{"issue":"11","key":"2026090218233043200_cit67","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1080\/00397919908086176","article-title":"Preparation\nOf Ceph-3-Em Esters Unaccompanied By \u03b43 To \u03b42 Isomerization Of The Cephalosporin Derivatives","volume":"29","author":"Lee","year":"1999","journal-title":"Synth. Commun."},{"issue":"7","key":"2026090218233043200_cit68","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1021\/jo00832a081","article-title":"Chemistry\nof Cephalosporin Antibiotics.\nXIX. Transformation of \u03942-Cephem to \u03943-Cephem by Oxidation-Reduction at Sulfur","volume":"35","author":"Kaiser","year":"1970","journal-title":"J.\nOrg. Chem."},{"key":"2026090218233043200_cit69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0166-1280(94)03792-J","article-title":"On the Mechanism of\nCephalosporin Isomerization","volume":"315","author":"Popa","year":"1994","journal-title":"J. Mol. Struct.:\nTHEOCHEM"},{"issue":"20","key":"2026090218233043200_cit70","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1016\/j.bmc.2008.09.010","article-title":"Bisphosphonated Fluoroquinolone Esters as Osteotropic\nProdrugs for the Prevention of Osteomyelitis","volume":"16","author":"Tanaka","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"2026090218233043200_cit71","unstructured":"Chan, M. F.; Castillo, R. S.; Li, Q.; Doppalapudi, V. R.; Hixton, M. S.; Lobl, T. J.\n          Improved Beta-Lactam Antibiotics. WO 01\/83492\nA1, 2001."},{"key":"2026090218233043200_cit72","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of Quinolone Action and\nResistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"1","key":"2026090218233043200_cit73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12866-017-1012-8","article-title":"Structure,\nGenetics and Worldwide\nSpread of New Delhi Metallo-\u03b2-Lactamase (NDM): A Threat to Public\nHealth","volume":"17","author":"Khan","year":"2017","journal-title":"BMC Microbiol."},{"issue":"4","key":"2026090218233043200_cit74","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel Carbapenem-Hydrolyzing Beta-Lactamase,\nKPC-1,\nfrom a Carbapenem-Resistant Strain of Klebsiella Pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"2026090218233043200_cit75","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: The\nVersatile Beta-Lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin. Microbiol.\nRev."},{"issue":"10","key":"2026090218233043200_cit76","doi-asserted-by":"publisher","first-page":"CD005405","DOI":"10.1002\/14651858.CD005405.pub4","article-title":"Oral Anti-Pseudomonal Antibiotics\nfor Cystic Fibrosis","author":"Remmington","year":"2016","journal-title":"Cochrane Database Syst.\nRev."},{"issue":"11","key":"2026090218233043200_cit77","doi-asserted-by":"publisher","first-page":"CD004197","DOI":"10.1002\/14651858.CD004197.pub5","article-title":"Antibiotic Strategies for Eradicating\nPseudomonas aeruginosa in People with Cystic Fibrosis","author":"Langton Hewer","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"2026090218233043200_cit78","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2147\/IDR.S173804","article-title":"Multidrug-Resistant\nPseudomonas aeruginosa from Sputum of Patients with Cystic Fibrosis\nDemonstrates a High Rate of Susceptibility to Ceftazidime-Avibactam","volume":"11","author":"Atkin","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"9","key":"2026090218233043200_cit79","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1021\/acs.jmedchem.8b00218","article-title":"A Synthetic Dual Drug Sideromycin Induces Gram-Negative\nBacteria To Commit Suicide with a Gram-Positive Antibiotic","volume":"61","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026090218233043200_cit80","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New Substructure\nFilters for Removal of Pan Assay Interference\nCompounds (PAINS) from Screening Libraries and for Their Exclusion\nin Bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"17","key":"2026090218233043200_cit81","doi-asserted-by":"publisher","first-page":"7076","DOI":"10.1021\/acs.jmedchem.5b01105","article-title":"An Aggregation Advisor\nfor Ligand Discovery","volume":"58","author":"Irwin","year":"2015","journal-title":"J. Med. Chem."},{"issue":"17","key":"2026090218233043200_cit82","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1055\/s-0035-1562454","article-title":"An Improved Synthesis of CENTA, a Chromogenic Substrate\nfor \u03b2-Lactamases","volume":"27","author":"Quotadamo","year":"2016","journal-title":"Synlett"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.8b01923","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/62\/9\/4411\/67035220\/acs.jmedchem.8b01923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/62\/9\/4411\/67035220\/acs.jmedchem.8b01923.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:23:46Z","timestamp":1788387826000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/62\/9\/4411\/1394614\/Exploitation-of-Antibiotic-Resistance-as-a-Novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":82,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,4,22]]},"published-print":{"date-parts":[[2019,5,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01923","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735597258.793559450","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01923.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01923.s002","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]}}}